A study for a 24 year old woman who takes Levora 0.15/30-21, Adderall 20, Escitalopram - from FDA reports

240 females aged 24 (±5) who take the same drugs are studied. This is a personalized study for a 24 year old female patient who has Birth Control, Attention Deficit Hyperactivity Disorder (Adhd), Depression. The study is created by eHealthMe based on reports from FDA.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.

On Jun, 13, 2018

240 females aged 24 (±5) who take Levora 0.15/30-21, Adderall 20, Escitalopram are studied.

Number of reports submitted per year:

Levora 0.15/30-21, Adderall 20, Escitalopram for a 24-year old woman.

Information of the patient in this study:

  • Age: 24
  • Gender: female
  • Conditions: Birth Control, Attention Deficit Hyperactivity Disorder (Adhd), Depression
  • Drugs taken:
    • Levora 0.15/30-21 (ethinyl estradiol; levonorgestrel)
    • Adderall 20 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate)
    • Escitalopram (escitalopram oxalate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Pulmonary Embolus(blockage of the lung artery by foreign matter or by a blood clot): 0 (0% of females aged 24 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  1. Eosinophilic pneumonia (eosinophil accumulates in the lung)
  2. Breathing difficulty
  3. Confusion
  4. Drowsiness
  5. Blood creatine phosphokinase increased
1 - 6 months:
  1. Suicidal ideation
  2. Pain
  3. Gallbladder disorder
  4. Injury
  5. Cholecystitis chronic (long lasting infection of gallbladder)
6 - 12 months:
  1. Cholecystitis acute (rapid infection of gallbladder)
  2. Gallstones (stone formation by bile component)
  3. Abdominal pain upper
  4. Cholecystitis chronic (long lasting infection of gallbladder)
  5. Gallbladder disease
1 - 2 years:
  1. Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Restless leg syndrome (a powerful urge to move your legs)
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
2 - 5 years:
  1. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  2. Gallbladder disorder
  3. Post cholecystectomy syndrome
  4. Abdominal pain
  5. Joint injury
5 - 10 years:
  1. Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  2. Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine)
  3. Dermal cyst
  4. Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
  5. Chest pain
10+ years:
  1. Nightmares (unpleasant dreams)
  2. Drowsiness
  3. Tonsillectomy
not specified:
  1. Drowsiness
  2. Drug ineffective
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Hypokalemia (low potassium)
  5. Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)

Top conditions involved for these people *:

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 23 people, 9.58%
  2. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 11 people, 4.58%
  3. Bipolar Disorder (mood disorder): 11 people, 4.58%
  4. Pain : 11 people, 4.58%
  5. Nausea (feeling of having an urge to vomit): 10 people, 4.17%

Top co-used drugs for these people *:

  1. Xyrem (59 people, 24.58%)
  2. Xanax (25 people, 10.42%)
  3. Yaz (21 people, 8.75%)
  4. Lamictal (21 people, 8.75%)
  5. Ambien (17 people, 7.08%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Related publications that referenced our studies

You may be interested in these posts

More posts for: Levora 0.15/30-21, Adderall 20, Escitalopram, Birth control, Attention deficit hyperactivity disorder (adhd), Pulmonary embolus, Depression

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.